Yuki Togashi
Santen (Japan)(JP)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, COVID-19 Clinical Research Studies, Cancer Genomics and Diagnostics
Most-Cited Works
- → RET, ROS1 and ALK fusions in lung cancer(2012)1,321 cited
- → KIF5B-ALK, a Novel Fusion Oncokinase Identified by an Immunohistochemistry-based Diagnostic System for ALK-positive Lung Cancer(2009)712 cited
- → Multiplex Reverse Transcription-PCR Screening for EML4-ALK Fusion Transcripts(2008)502 cited
- → EML4-ALK Fusion Is Linked to Histological Characteristics in a Subset of Lung Cancers(2008)464 cited
- → EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology, and young onset(2009)443 cited
- → Identification of Novel Isoforms of the EML4-ALK Transforming Gene in Non–Small Cell Lung Cancer(2008)437 cited
- → KLC1-ALK: A Novel Fusion in Lung Cancer Identified Using a Formalin-Fixed Paraffin-Embedded Tissue Only(2012)261 cited
- → Identification of anaplastic lymphoma kinase fusions in renal cancer(2012)139 cited
- → Frequent BCOR aberrations in extranodal NK/T‐Cell lymphoma, nasal type(2016)128 cited
- → Pulmonary Inflammatory Myofibroblastic Tumor Expressing a Novel Fusion, PPFIBP1–ALK: Reappraisal of Anti-ALK Immunohistochemistry as a Tool for Novel ALK Fusion Identification(2011)112 cited